Anika Therapeutics, Inc. (ANIK) Tops Q1 Revenue Tops Views
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.17 -3.9%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.97, $0.72 better than the analyst estimate of $0.25. Revenue for the quarter came in at $34 million versus the consensus estimate of $16.03 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
